AI Summary
Thinking
Thinking
We reviewed 3 live results for exome sequencing and narrowed them down to the 3 options that look most worth comparing first.
The options are Exome Sequencing, GENEQUALITY® Whole Exome Sequencing Kit and Exome Sequencing.
Source: CeGaT GmbH
Description
CeGaT GmbH provides comprehensive Whole Exome Sequencing (WES) services, sequencing protein-coding genomic regions using Illumina paired-end platforms and Twist Bioscience target enrichment. Processed in an accredited laboratory in Tübingen, Germany, the service supports research in rare diseases, oncology, and population genetics across human and mouse samples. Deliverables include structured project reports, FASTQ data, and scalable bioinformatic analysis levels utilizing the Illumina DRAGEN Bio-IT Platform with standard turnaround times of 15 days.
Best for
researchers, physicians, rare disease research and tumor profiling
Rate this product
Source: AB ANALITICA Srl
Description
GENEQUALITY® Whole Exome Sequencing Kit by AB ANALITICA is a CE-IVD certified device compliant with EU Regulation 2017/746 (IVDR) for preparing NGS genomic libraries enriched for the human exome and mitochondrial genome. Validated on whole blood DNA (10ng to 500ng) and Illumina platforms such as NovaSeq6000 and NextSeq500/550, it covers approximately 42Mb across 19,441 genes to detect single nucleotide variants, insertions, deletions, single nucleotide polymorphisms, and copy number variations for genetic disease analysis.
Best for
Clinical diagnostic laboratories, Genetics researchers, Whole exome sequencing and Mitochondrial genome analysis
Rate this product
Source: MGZ
Description
MGZ offers exome sequencing diagnostic services, including Clinical Exome and Whole Exome testing, using next-generation sequencing to identify disease-causing genetic variants. Designed for patients with suspected hereditary diseases or rare disorders where standard gene panels fail to yield a diagnosis, testing is available in single and trio analysis formats with turnaround times of 8 to 12 weeks.
Best for
patients with suspected hereditary diseases, individuals with undiagnosed rare genetic disorders, cases where phenotype-based gene panels are inconclusive and first-line testing for heterogeneous conditions
Rate this product
| Compare | #1Exome Sequencing | #2GENEQUALITY® Whole Exome Sequencing Kit | #3Exome Sequencing |
|---|---|---|---|
| Source | CeGaT GmbH | AB ANALITICA Srl | MGZ |
| Description | CeGaT GmbH provides comprehensive Whole Exome Sequencing (WES) services, sequencing protein-coding genomic regions using Illumina paired-end platforms and Twist Bioscience target enrichment. Processed in an accredited laboratory in Tübingen, Germany, the service supports research in rare diseases, oncology, and population genetics across human and mouse samples. Deliverables include structured project reports, FASTQ data, and scalable bioinformatic analysis levels utilizing the Illumina DRAGEN Bio-IT Platform with standard turnaround times of 15 days. | GENEQUALITY® Whole Exome Sequencing Kit by AB ANALITICA is a CE-IVD certified device compliant with EU Regulation 2017/746 (IVDR) for preparing NGS genomic libraries enriched for the human exome and mitochondrial genome. Validated on whole blood DNA (10ng to 500ng) and Illumina platforms such as NovaSeq6000 and NextSeq500/550, it covers approximately 42Mb across 19,441 genes to detect single nucleotide variants, insertions, deletions, single nucleotide polymorphisms, and copy number variations for genetic disease analysis. | MGZ offers exome sequencing diagnostic services, including Clinical Exome and Whole Exome testing, using next-generation sequencing to identify disease-causing genetic variants. Designed for patients with suspected hereditary diseases or rare disorders where standard gene panels fail to yield a diagnosis, testing is available in single and trio analysis formats with turnaround times of 8 to 12 weeks. |
| Best for | researchers, physicians, rare disease research and tumor profiling | Clinical diagnostic laboratories, Genetics researchers, Whole exome sequencing and Mitochondrial genome analysis | patients with suspected hereditary diseases, individuals with undiagnosed rare genetic disorders, cases where phenotype-based gene panels are inconclusive and first-line testing for heterogeneous conditions |
| Action | CeGaT GmbH | AB ANALITICA Srl | |
| Rate this product |
"Exome Sequencing from CeGaT GmbH."
Note: TopFind AI compiles product and service information for general comparison purposes only.